English

YIELD10 BIOSCIENCE, INC.

EDGAR

YTEN Quarterly report (10-Q) · filed 2024-08-14

94 filing records in this dataset, filed from 2006-12-13 to 2024-08-14. Reported financial figures are available; chart coverage varies by period.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

450 thousand USD

2024 Q2 · USD

Exact inputs and evidence

Revenue: 450000 USD Source

Operating margin

-711.78%

2024 Q2 · %

Exact inputs and evidence

Operating Income: -3203000 USD Source
Revenue: 450000 USD Source

Operating cash flow

-574 thousand USD

2024 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1477000 USD Source
Operating Cash Flow: -903000 USD Source

Free cash flow

-574 thousand USD

2024 Q2 · USD

Exact inputs and evidence

Operating Cash Flow: -1477000 USD Source
Operating Cash Flow: -903000 USD Source
Capital Expenditure: 0 USD Source
Capital Expenditure: 0 USD Source

Cash and cash equivalents: 733 thousand USD 2024-06-30 Source
Exact value

733000 USD
Long-term debt including current maturities: Not available
Shares outstanding: 642 thousand shares 2024-06-30 Source
Exact value

642497 shares

Reported share-count change

-89.47% · -5.46 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence

6100263 shares · 2023-06-30· Source
642497 shares · 2024-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-12.7 million USD

2023-07-01 – 2024-06-30

Exact inputs and evidence

Net income: -3726000 USD · 2023-07-01 – 2023-09-30 Source
Net income: -14455000 USD · 2023-01-01 – 2023-12-31 Source
Net income: -11189000 USD · 2023-01-01 – 2023-09-30 Source
Net income: -2472000 USD · 2024-01-01 – 2024-03-31 Source
Net income: -3238000 USD · 2024-04-01 – 2024-06-30 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2024-08-14.

Financial data available through: 2023-12-31.

Coverage by financial measure

Revenue: 11 of 11 periods available· newest 2023-12-31
Operating income: 11 of 11 periods available· newest 2023-12-31
Net income: 11 of 11 periods available· newest 2023-12-31
Operating cash flow: 11 of 11 periods available· newest 2023-12-31
Capital expenditure: 11 of 11 periods available· newest 2023-12-31
Total assets: 11 of 11 periods available· newest 2023-12-31
Total liabilities: 11 of 11 periods available· newest 2023-12-31
Current assets: 11 of 11 periods available· newest 2023-12-31
Current liabilities: 11 of 11 periods available· newest 2023-12-31
Cash and cash equivalents: 11 of 11 periods available· newest 2023-12-31
long term debt: No compatible figures in this window
Shares outstanding: 11 of 11 periods available· newest 2023-12-31

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-86.7%

Prior period

USD 450,000

2022-01-01 – 2022-12-31
Current period

USD 60,000

2023-01-01 – 2023-12-31

Exact inputs and evidence

60000 − 450000 = -390000 USD

450000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
60000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · YIELD10 BIOSCIENCE, INC. · 2023-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Year-over-year change in Revenue: -390000 USD Concept: fundies:Revenue Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 60000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#781602 Filing: 000112170224000021 Input fundies:Revenue: 450000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#782236 Filing: 000112170224000021
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 889,000

Prior period

−USD 13.57 million

2022-01-01 – 2022-12-31
Current period

−USD 14.46 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-14455000 − -13566000 = -889000 USD

-13566000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-14455000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · YIELD10 BIOSCIENCE, INC. · 2023-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Year-over-year change in Net income: -889000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -14455000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#941938 Filing: 000112170224000021 Input fundies:NetIncome: -13566000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#907029 Filing: 000112170224000021
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
+USD 1.34 million

Prior period

−USD 11.4 million

2022-01-01 – 2022-12-31
Current period

−USD 10.07 million

2023-01-01 – 2023-12-31

Exact inputs and evidence

-10068000 − -11404000 = 1336000 USD

-11404000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
-10068000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · YIELD10 BIOSCIENCE, INC. · 2023-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Year-over-year change in Operating cash flow: 1336000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -10068000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#842865 Filing: 000112170224000021 Input fundies:OperatingCashFlow: -11404000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#843527 Filing: 000112170224000021
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
-70.1%

Prior period

USD 154,000

2022-01-01 – 2022-12-31
Current period

USD 46,000

2023-01-01 – 2023-12-31

Exact inputs and evidence

46000 − 154000 = -108000 USD

154000 USD · 2022-01-01 – 2022-12-31
Inspect prior input Prior source
46000 USD · 2023-01-01 – 2023-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · YIELD10 BIOSCIENCE, INC. · 2023-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Year-over-year change in Capital expenditure: -108000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 46000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#845656 Filing: 000112170224000021 Input fundies:CapitalExpenditure: 154000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#846218 Filing: 000112170224000021
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2023 2023-01-01 – 2023-12-31

Revenue USD 60,000 100% of revenue
Operating costs Derived USD 14.48 million 24,128% of revenue
Operating income −USD 14.42 million −24,028% of revenue
Tax, interest and other Derived USD 38,000 63% of revenue
Net income −USD 14.46 million −24,092% of revenue

Cash

Operating cash flow −USD 10.07 million −16,780% of revenue
Capital expenditure USD 46,000 77% of revenue
Free cash flow Derived −USD 10.11 million −16,857% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

2014 Operating loss: operating costs were 1,058% of revenue.
2015 Operating loss: operating costs were 1,024% of revenue.
2016 Operating loss: operating costs were 984% of revenue.
2017 Operating loss: operating costs were 1,083% of revenue.
2018 Operating loss: operating costs were 1,776% of revenue.
2019 Operating loss: operating costs were 1,167% of revenue.
2020 Operating loss: operating costs were 1,303% of revenue.
2021 Operating loss: operating costs were 2,004% of revenue.
2022 Operating loss: operating costs were 3,089% of revenue.
2023 Operating loss: operating costs were 24,128% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
2014 2014-01-01 – 2014-12-31	2800000	29629000 Derived	-26829000	2705000 Derived	-29534000	-24708000 Derived	Source 2014-01-01 – 2014-12-31: 2800000 USD Inspect Revenue Open source 2014-01-01 – 2014-12-31: -26829000 USD Inspect Operating Income Open source 2014-01-01 – 2014-12-31: -29534000 USD Inspect Net Income Open source 2014-01-01 – 2014-12-31: -24536000 USD Inspect Operating Cash Flow Open source 2014-01-01 – 2014-12-31: 172000 USD Inspect Capital Expenditure Open source
2015 2015-01-01 – 2015-12-31	1350000	13819000 Derived	-12469000	11212000 Derived	-23681000	-22517000 Derived	Source 2015-01-01 – 2015-12-31: 1350000 USD Inspect Revenue Open source 2015-01-01 – 2015-12-31: -12469000 USD Inspect Operating Income Open source 2015-01-01 – 2015-12-31: -23681000 USD Inspect Net Income Open source 2015-01-01 – 2015-12-31: -21863000 USD Inspect Operating Cash Flow Open source 2015-01-01 – 2015-12-31: 654000 USD Inspect Capital Expenditure Open source
2016 2016-01-01 – 2016-12-31	1159000	11407000 Derived	-10248000	-2644000 Derived	-7604000	-15156000 Derived	Source 2016-01-01 – 2016-12-31: 1159000 USD Inspect Revenue Open source 2016-01-01 – 2016-12-31: -10248000 USD Inspect Operating Income Open source 2016-01-01 – 2016-12-31: -7604000 USD Inspect Net Income Open source 2016-01-01 – 2016-12-31: -14404000 USD Inspect Operating Cash Flow Open source 2016-01-01 – 2016-12-31: 752000 USD Inspect Capital Expenditure Open source
2017 2017-01-01 – 2017-12-31	944000	10227000 Derived	-9283000	113000 Derived	-9396000	-8208000 Derived	Source 2017-01-01 – 2017-12-31: 944000 USD Inspect Revenue Open source 2017-01-01 – 2017-12-31: -9283000 USD Inspect Operating Income Open source 2017-01-01 – 2017-12-31: -9396000 USD Inspect Net Income Open source 2017-01-01 – 2017-12-31: -8202000 USD Inspect Operating Cash Flow Open source 2017-01-01 – 2017-12-31: 6000 USD Inspect Capital Expenditure Open source
2018 2018-01-01 – 2018-12-31	556000	9875000 Derived	-9319000	-134000 Derived	-9185000	-8796000 Derived	Source 2018-01-01 – 2018-12-31: 556000 USD Inspect Revenue Open source 2018-01-01 – 2018-12-31: -9319000 USD Inspect Operating Income Open source 2018-01-01 – 2018-12-31: -9185000 USD Inspect Net Income Open source 2018-01-01 – 2018-12-31: -8754000 USD Inspect Operating Cash Flow Open source 2018-01-01 – 2018-12-31: 42000 USD Inspect Capital Expenditure Open source
2019 2019-01-01 – 2019-12-31	806000	9402000 Derived	-8596000	4360000 Derived	-12956000	-8715000 Derived	Source 2019-01-01 – 2019-12-31: 806000 USD Inspect Revenue Open source 2019-01-01 – 2019-12-31: -8596000 USD Inspect Operating Income Open source 2019-01-01 – 2019-12-31: -12956000 USD Inspect Net Income Open source 2019-01-01 – 2019-12-31: -8654000 USD Inspect Operating Cash Flow Open source 2019-01-01 – 2019-12-31: 61000 USD Inspect Capital Expenditure Open source
2020 2020-01-01 – 2020-12-31	799000	10408000 Derived	-9609000	597000 Derived	-10206000	-8735000 Derived	Source 2020-01-01 – 2020-12-31: 799000 USD Inspect Revenue Open source 2020-01-01 – 2020-12-31: -9609000 USD Inspect Operating Income Open source 2020-01-01 – 2020-12-31: -10206000 USD Inspect Net Income Open source 2020-01-01 – 2020-12-31: -8659000 USD Inspect Operating Cash Flow Open source 2020-01-01 – 2020-12-31: 76000 USD Inspect Capital Expenditure Open source
2021 2021-01-01 – 2021-12-31	614000	12306000 Derived	-11692000	-661000 Derived	-11031000	-9442000 Derived	Source 2021-01-01 – 2021-12-31: 614000 USD Inspect Revenue Open source 2021-01-01 – 2021-12-31: -11692000 USD Inspect Operating Income Open source 2021-01-01 – 2021-12-31: -11031000 USD Inspect Net Income Open source 2021-01-01 – 2021-12-31: -9253000 USD Inspect Operating Cash Flow Open source 2021-01-01 – 2021-12-31: 189000 USD Inspect Capital Expenditure Open source
2022 2022-01-01 – 2022-12-31	450000	13901000 Derived	-13451000	115000 Derived	-13566000	-11558000 Derived	Source 2022-01-01 – 2022-12-31: 450000 USD Inspect Revenue Open source 2022-01-01 – 2022-12-31: -13451000 USD Inspect Operating Income Open source 2022-01-01 – 2022-12-31: -13566000 USD Inspect Net Income Open source 2022-01-01 – 2022-12-31: -11404000 USD Inspect Operating Cash Flow Open source 2022-01-01 – 2022-12-31: 154000 USD Inspect Capital Expenditure Open source
2023 2023-01-01 – 2023-12-31	60000	14477000 Derived	-14417000	38000 Derived	-14455000	-10114000 Derived	Source 2023-01-01 – 2023-12-31: 60000 USD Inspect Revenue Open source 2023-01-01 – 2023-12-31: -14417000 USD Inspect Operating Income Open source 2023-01-01 – 2023-12-31: -14455000 USD Inspect Net Income Open source 2023-01-01 – 2023-12-31: -10068000 USD Inspect Operating Cash Flow Open source 2023-01-01 – 2023-12-31: 46000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 60K 2023

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Revenue	2800000	Revenue: 2800000 Open source
20152015-12-31	Revenue	1350000	Revenue: 1350000 Open source
20162016-12-31	Revenue	1159000	Revenue: 1159000 Open source
20172017-12-31	Revenue	944000	Revenue: 944000 Open source
20182018-12-31	Revenue	556000	Revenue: 556000 Open source
20192019-12-31	Revenue	806000	Revenue: 806000 Open source
20202020-12-31	Revenue	799000	Revenue: 799000 Open source
20212021-12-31	Revenue	614000	Revenue: 614000 Open source
20222022-12-31	Revenue	450000	Revenue: 450000 Open source
20232023-12-31	Revenue	60000	Revenue: 60000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-86.7% 2023

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Year over year	-25.9%	Revenue: 2800000 Open source Revenue: 3778000 Open source
20152015-12-31	Year over year	-51.8%	Revenue: 1350000 Open source Revenue: 2800000 Open source
20162016-12-31	Year over year	-14.1%	Revenue: 1159000 Open source Revenue: 1350000 Open source
20172017-12-31	Year over year	-18.6%	Revenue: 944000 Open source Revenue: 1159000 Open source
20182018-12-31	Year over year	-41.1%	Revenue: 556000 Open source Revenue: 944000 Open source
20192019-12-31	Year over year	45%	Revenue: 806000 Open source Revenue: 556000 Open source
20202020-12-31	Year over year	-0.9%	Revenue: 799000 Open source Revenue: 806000 Open source
20212021-12-31	Year over year	-23.2%	Revenue: 614000 Open source Revenue: 799000 Open source
20222022-12-31	Year over year	-26.7%	Revenue: 450000 Open source Revenue: 614000 Open source
20232023-12-31	Year over year	-86.7%	Revenue: 60000 Open source Revenue: 450000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -24,028.3% 2023

Net margin -24,091.7% 2023

Free cash flow margin -16,856.7% 2023

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Operating margin	-958.2%	Operating Income: -26829000 Open source Revenue: 2800000 Open source
20152015-12-31	Operating margin	-923.6%	Operating Income: -12469000 Open source Revenue: 1350000 Open source
20162016-12-31	Operating margin	-884.2%	Operating Income: -10248000 Open source Revenue: 1159000 Open source
20172017-12-31	Operating margin	-983.4%	Operating Income: -9283000 Open source Revenue: 944000 Open source
20182018-12-31	Operating margin	-1,676.1%	Operating Income: -9319000 Open source Revenue: 556000 Open source
20192019-12-31	Operating margin	-1,066.5%	Operating Income: -8596000 Open source Revenue: 806000 Open source
20202020-12-31	Operating margin	-1,202.6%	Operating Income: -9609000 Open source Revenue: 799000 Open source
20212021-12-31	Operating margin	-1,904.2%	Operating Income: -11692000 Open source Revenue: 614000 Open source
20222022-12-31	Operating margin	-2,989.1%	Operating Income: -13451000 Open source Revenue: 450000 Open source
20232023-12-31	Operating margin	-24,028.3%	Operating Income: -14417000 Open source Revenue: 60000 Open source
20142014-12-31	Net margin	-1,054.8%	Net Income: -29534000 Open source Revenue: 2800000 Open source
20152015-12-31	Net margin	-1,754.1%	Net Income: -23681000 Open source Revenue: 1350000 Open source
20162016-12-31	Net margin	-656.1%	Net Income: -7604000 Open source Revenue: 1159000 Open source
20172017-12-31	Net margin	-995.3%	Net Income: -9396000 Open source Revenue: 944000 Open source
20182018-12-31	Net margin	-1,652%	Net Income: -9185000 Open source Revenue: 556000 Open source
20192019-12-31	Net margin	-1,607.4%	Net Income: -12956000 Open source Revenue: 806000 Open source
20202020-12-31	Net margin	-1,277.3%	Net Income: -10206000 Open source Revenue: 799000 Open source
20212021-12-31	Net margin	-1,796.6%	Net Income: -11031000 Open source Revenue: 614000 Open source
20222022-12-31	Net margin	-3,014.7%	Net Income: -13566000 Open source Revenue: 450000 Open source
20232023-12-31	Net margin	-24,091.7%	Net Income: -14455000 Open source Revenue: 60000 Open source
20142014-12-31	Free cash flow margin	-882.4%	Revenue: 2800000 Open source Operating Cash Flow: -24536000 Open source Capital Expenditure: 172000 Open source
20152015-12-31	Free cash flow margin	-1,667.9%	Revenue: 1350000 Open source Operating Cash Flow: -21863000 Open source Capital Expenditure: 654000 Open source
20162016-12-31	Free cash flow margin	-1,307.7%	Revenue: 1159000 Open source Operating Cash Flow: -14404000 Open source Capital Expenditure: 752000 Open source
20172017-12-31	Free cash flow margin	-869.5%	Revenue: 944000 Open source Operating Cash Flow: -8202000 Open source Capital Expenditure: 6000 Open source
20182018-12-31	Free cash flow margin	-1,582%	Revenue: 556000 Open source Operating Cash Flow: -8754000 Open source Capital Expenditure: 42000 Open source
20192019-12-31	Free cash flow margin	-1,081.3%	Revenue: 806000 Open source Operating Cash Flow: -8654000 Open source Capital Expenditure: 61000 Open source
20202020-12-31	Free cash flow margin	-1,093.2%	Revenue: 799000 Open source Operating Cash Flow: -8659000 Open source Capital Expenditure: 76000 Open source
20212021-12-31	Free cash flow margin	-1,537.8%	Revenue: 614000 Open source Operating Cash Flow: -9253000 Open source Capital Expenditure: 189000 Open source
20222022-12-31	Free cash flow margin	-2,568.4%	Revenue: 450000 Open source Operating Cash Flow: -11404000 Open source Capital Expenditure: 154000 Open source
20232023-12-31	Free cash flow margin	-16,856.7%	Revenue: 60000 Open source Operating Cash Flow: -10068000 Open source Capital Expenditure: 46000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -10.1M 2023

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Operating cash flow	-24536000	Operating Cash Flow: -24536000 Open source
20152015-12-31	Operating cash flow	-21863000	Operating Cash Flow: -21863000 Open source
20162016-12-31	Operating cash flow	-14404000	Operating Cash Flow: -14404000 Open source
20172017-12-31	Operating cash flow	-8202000	Operating Cash Flow: -8202000 Open source
20182018-12-31	Operating cash flow	-8754000	Operating Cash Flow: -8754000 Open source
20192019-12-31	Operating cash flow	-8654000	Operating Cash Flow: -8654000 Open source
20202020-12-31	Operating cash flow	-8659000	Operating Cash Flow: -8659000 Open source
20212021-12-31	Operating cash flow	-9253000	Operating Cash Flow: -9253000 Open source
20222022-12-31	Operating cash flow	-11404000	Operating Cash Flow: -11404000 Open source
20232023-12-31	Operating cash flow	-10068000	Operating Cash Flow: -10068000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -10.1M 2023

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
20142014-12-31	Free cash flow	-24708000	Operating Cash Flow: -24536000 Open source Capital Expenditure: 172000 Open source
20152015-12-31	Free cash flow	-22517000	Operating Cash Flow: -21863000 Open source Capital Expenditure: 654000 Open source
20162016-12-31	Free cash flow	-15156000	Operating Cash Flow: -14404000 Open source Capital Expenditure: 752000 Open source
20172017-12-31	Free cash flow	-8208000	Operating Cash Flow: -8202000 Open source Capital Expenditure: 6000 Open source
20182018-12-31	Free cash flow	-8796000	Operating Cash Flow: -8754000 Open source Capital Expenditure: 42000 Open source
20192019-12-31	Free cash flow	-8715000	Operating Cash Flow: -8654000 Open source Capital Expenditure: 61000 Open source
20202020-12-31	Free cash flow	-8735000	Operating Cash Flow: -8659000 Open source Capital Expenditure: 76000 Open source
20212021-12-31	Free cash flow	-9442000	Operating Cash Flow: -9253000 Open source Capital Expenditure: 189000 Open source
20222022-12-31	Free cash flow	-11558000	Operating Cash Flow: -11404000 Open source Capital Expenditure: 154000 Open source
20232023-12-31	Free cash flow	-10114000	Operating Cash Flow: -10068000 Open source Capital Expenditure: 46000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

163.6% 2023

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Liabilities / assets	18.8%	Total Liabilities: 4339000 Open source Total Assets: 23135000 Open source
20152015-12-31	Liabilities / assets	23.8%	Total Liabilities: 4060000 Open source Total Assets: 17088000 Open source
20162016-12-31	Liabilities / assets	40.7%	Total Liabilities: 4379000 Open source Total Assets: 10748000 Open source
20172017-12-31	Liabilities / assets	20%	Total Liabilities: 3380000 Open source Total Assets: 16882000 Open source
20182018-12-31	Liabilities / assets	56%	Total Liabilities: 7262000 Open source Total Assets: 12960000 Open source
20192019-12-31	Liabilities / assets	124.4%	Total Liabilities: 20803000 Open source Total Assets: 16718000 Open source
20202020-12-31	Liabilities / assets	34.4%	Total Liabilities: 4990000 Open source Total Assets: 14522000 Open source
20212021-12-31	Liabilities / assets	21.5%	Total Liabilities: 4389000 Open source Total Assets: 20415000 Open source
20222022-12-31	Liabilities / assets	45.6%	Total Liabilities: 3685000 Open source Total Assets: 8085000 Open source
20232023-12-31	Liabilities / assets	163.6%	Total Liabilities: 6390000 Open source Total Assets: 3907000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

0.29× 2023

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
20142014-12-31	Current assets / current liabilities	5.24×	Current Assets: 21965000 Open source Current Liabilities: 4189000 Open source
20152015-12-31	Current assets / current liabilities	3.8×	Current Assets: 14850000 Open source Current Liabilities: 3910000 Open source
20162016-12-31	Current assets / current liabilities	2.85×	Current Assets: 7860000 Open source Current Liabilities: 2758000 Open source
20172017-12-31	Current assets / current liabilities	6.28×	Current Assets: 14917000 Open source Current Liabilities: 2375000 Open source
20182018-12-31	Current assets / current liabilities	3.89×	Current Assets: 6377000 Open source Current Liabilities: 1641000 Open source
20192019-12-31	Current assets / current liabilities	5.29×	Current Assets: 11684000 Open source Current Liabilities: 2207000 Open source
20202020-12-31	Current assets / current liabilities	5.7×	Current Assets: 10342000 Open source Current Liabilities: 1814000 Open source
20212021-12-31	Current assets / current liabilities	9.59×	Current Assets: 16624000 Open source Current Liabilities: 1733000 Open source
20222022-12-31	Current assets / current liabilities	3.12×	Current Assets: 5018000 Open source Current Liabilities: 1610000 Open source
20232023-12-31	Current assets / current liabilities	0.29×	Current Assets: 1400000 Open source Current Liabilities: 4865000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
2014 2014-01-01 – 2014-12-31	−USD 29.53 million Exact value Exact value: -29534000 USD 2014-01-01 – 2014-12-31: -29534000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2014-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -29534000 USD Concept: fundies:NetIncome Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:NetIncome: -29534000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170216000055/mblx-20151231.xml#218703 Filing: 000112170216000055 The citation records this snapshot. The page link may show a newer release later.	−USD 24.54 million Exact value Exact value: -24536000 USD 2014-01-01 – 2014-12-31: -24536000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2014-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -24536000 USD Concept: fundies:OperatingCashFlow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -24536000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170216000055/mblx-20151231.xml#216534 Filing: 000112170216000055 The citation records this snapshot. The page link may show a newer release later.	USD 172,000 Exact value Exact value: 172000 USD 2014-01-01 – 2014-12-31: 172000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2014-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 172000 USD Concept: fundies:CapitalExpenditure Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2014-12-31&surface=latest&period_type=duration&start=2014-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 172000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170216000055/mblx-20151231.xml#235021 Filing: 000112170216000055 The citation records this snapshot. The page link may show a newer release later.	−USD 24.71 million Calculation and evidence -24536000 − 172000 USD Exact free cash flow: -24708000 USD 2014-01-01 – 2014-12-31: -24536000 USD · Inspect Operating Cash Flow · Source 2014-01-01 – 2014-12-31: 172000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2014-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -24708000 USD Concept: free-cash-flow Period: 2014-01-01 to 2014-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -24536000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170216000055/mblx-20151231.xml#216534 Filing: 000112170216000055 Input fundies:CapitalExpenditure: 172000 USD (2014-01-01 to 2014-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170216000055/mblx-20151231.xml#235021 Filing: 000112170216000055 The citation records this snapshot. The page link may show a newer release later.
2015 2015-01-01 – 2015-12-31	−USD 23.68 million Exact value Exact value: -23681000 USD 2015-01-01 – 2015-12-31: -23681000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2015-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -23681000 USD Concept: fundies:NetIncome Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:NetIncome: -23681000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170217000024/mblx-20161231.xml#167856 Filing: 000112170217000024 The citation records this snapshot. The page link may show a newer release later.	−USD 21.86 million Exact value Exact value: -21863000 USD 2015-01-01 – 2015-12-31: -21863000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2015-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -21863000 USD Concept: fundies:OperatingCashFlow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -21863000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170217000024/mblx-20161231.xml#167352 Filing: 000112170217000024 The citation records this snapshot. The page link may show a newer release later.	USD 654,000 Exact value Exact value: 654000 USD 2015-01-01 – 2015-12-31: 654000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2015-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 654000 USD Concept: fundies:CapitalExpenditure Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2015-12-31&surface=latest&period_type=duration&start=2015-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 654000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170217000024/mblx-20161231.xml#177643 Filing: 000112170217000024 The citation records this snapshot. The page link may show a newer release later.	−USD 22.52 million Calculation and evidence -21863000 − 654000 USD Exact free cash flow: -22517000 USD 2015-01-01 – 2015-12-31: -21863000 USD · Inspect Operating Cash Flow · Source 2015-01-01 – 2015-12-31: 654000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2015-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -22517000 USD Concept: free-cash-flow Period: 2015-01-01 to 2015-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -21863000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170217000024/mblx-20161231.xml#167352 Filing: 000112170217000024 Input fundies:CapitalExpenditure: 654000 USD (2015-01-01 to 2015-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170217000024/mblx-20161231.xml#177643 Filing: 000112170217000024 The citation records this snapshot. The page link may show a newer release later.
2016 2016-01-01 – 2016-12-31	−USD 7.6 million Exact value Exact value: -7604000 USD 2016-01-01 – 2016-12-31: -7604000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2016-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -7604000 USD Concept: fundies:NetIncome Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7604000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170218000009/mblx-20171231.xml#197791 Filing: 000112170218000009 The citation records this snapshot. The page link may show a newer release later.	−USD 14.4 million Exact value Exact value: -14404000 USD 2016-01-01 – 2016-12-31: -14404000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2016-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -14404000 USD Concept: fundies:OperatingCashFlow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -14404000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170218000009/mblx-20171231.xml#197288 Filing: 000112170218000009 The citation records this snapshot. The page link may show a newer release later.	USD 752,000 Exact value Exact value: 752000 USD 2016-01-01 – 2016-12-31: 752000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2016-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 752000 USD Concept: fundies:CapitalExpenditure Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2016-12-31&surface=latest&period_type=duration&start=2016-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 752000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170218000009/mblx-20171231.xml#207414 Filing: 000112170218000009 The citation records this snapshot. The page link may show a newer release later.	−USD 15.16 million Calculation and evidence -14404000 − 752000 USD Exact free cash flow: -15156000 USD 2016-01-01 – 2016-12-31: -14404000 USD · Inspect Operating Cash Flow · Source 2016-01-01 – 2016-12-31: 752000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2016-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -15156000 USD Concept: free-cash-flow Period: 2016-01-01 to 2016-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -14404000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170218000009/mblx-20171231.xml#197288 Filing: 000112170218000009 Input fundies:CapitalExpenditure: 752000 USD (2016-01-01 to 2016-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170218000009/mblx-20171231.xml#207414 Filing: 000112170218000009 The citation records this snapshot. The page link may show a newer release later.
2017 2017-01-01 – 2017-12-31	−USD 9.4 million Exact value Exact value: -9396000 USD 2017-01-01 – 2017-12-31: -9396000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2017-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -9396000 USD Concept: fundies:NetIncome Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9396000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170219000007/mblx-20181231.xml#185181 Filing: 000112170219000007 The citation records this snapshot. The page link may show a newer release later.	−USD 8.2 million Exact value Exact value: -8202000 USD 2017-01-01 – 2017-12-31: -8202000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2017-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -8202000 USD Concept: fundies:OperatingCashFlow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8202000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170219000007/mblx-20181231.xml#184759 Filing: 000112170219000007 The citation records this snapshot. The page link may show a newer release later.	USD 6,000 Exact value Exact value: 6000 USD 2017-01-01 – 2017-12-31: 6000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2017-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 6000 USD Concept: fundies:CapitalExpenditure Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2017-12-31&surface=latest&period_type=duration&start=2017-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 6000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170219000007/mblx-20181231.xml#196299 Filing: 000112170219000007 The citation records this snapshot. The page link may show a newer release later.	−USD 8.21 million Calculation and evidence -8202000 − 6000 USD Exact free cash flow: -8208000 USD 2017-01-01 – 2017-12-31: -8202000 USD · Inspect Operating Cash Flow · Source 2017-01-01 – 2017-12-31: 6000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2017-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -8208000 USD Concept: free-cash-flow Period: 2017-01-01 to 2017-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8202000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170219000007/mblx-20181231.xml#184759 Filing: 000112170219000007 Input fundies:CapitalExpenditure: 6000 USD (2017-01-01 to 2017-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170219000007/mblx-20181231.xml#196299 Filing: 000112170219000007 The citation records this snapshot. The page link may show a newer release later.
2018 2018-01-01 – 2018-12-31	−USD 9.19 million Exact value Exact value: -9185000 USD 2018-01-01 – 2018-12-31: -9185000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2018-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -9185000 USD Concept: fundies:NetIncome Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:NetIncome: -9185000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170220000019/mblx-20191231.xml#240439 Filing: 000112170220000019 The citation records this snapshot. The page link may show a newer release later.	−USD 8.75 million Exact value Exact value: -8754000 USD 2018-01-01 – 2018-12-31: -8754000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2018-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -8754000 USD Concept: fundies:OperatingCashFlow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8754000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170220000019/mblx-20191231.xml#240017 Filing: 000112170220000019 The citation records this snapshot. The page link may show a newer release later.	USD 42,000 Exact value Exact value: 42000 USD 2018-01-01 – 2018-12-31: 42000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2018-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 42000 USD Concept: fundies:CapitalExpenditure Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2018-12-31&surface=latest&period_type=duration&start=2018-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 42000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170220000019/mblx-20191231.xml#250596 Filing: 000112170220000019 The citation records this snapshot. The page link may show a newer release later.	−USD 8.8 million Calculation and evidence -8754000 − 42000 USD Exact free cash flow: -8796000 USD 2018-01-01 – 2018-12-31: -8754000 USD · Inspect Operating Cash Flow · Source 2018-01-01 – 2018-12-31: 42000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2018-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -8796000 USD Concept: free-cash-flow Period: 2018-01-01 to 2018-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8754000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170220000019/mblx-20191231.xml#240017 Filing: 000112170220000019 Input fundies:CapitalExpenditure: 42000 USD (2018-01-01 to 2018-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170220000019/mblx-20191231.xml#250596 Filing: 000112170220000019 The citation records this snapshot. The page link may show a newer release later.
2019 2019-01-01 – 2019-12-31	−USD 12.96 million Exact value Exact value: -12956000 USD 2019-01-01 – 2019-12-31: -12956000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2019-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -12956000 USD Concept: fundies:NetIncome Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:NetIncome: -12956000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170221000010/yten-20201231.htm#1074778 Filing: 000112170221000010 The citation records this snapshot. The page link may show a newer release later.	−USD 8.65 million Exact value Exact value: -8654000 USD 2019-01-01 – 2019-12-31: -8654000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2019-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -8654000 USD Concept: fundies:OperatingCashFlow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8654000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170221000010/yten-20201231.htm#954183 Filing: 000112170221000010 The citation records this snapshot. The page link may show a newer release later.	USD 61,000 Exact value Exact value: 61000 USD 2019-01-01 – 2019-12-31: 61000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2019-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 61000 USD Concept: fundies:CapitalExpenditure Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2019-12-31&surface=latest&period_type=duration&start=2019-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 61000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170221000010/yten-20201231.htm#957777 Filing: 000112170221000010 The citation records this snapshot. The page link may show a newer release later.	−USD 8.72 million Calculation and evidence -8654000 − 61000 USD Exact free cash flow: -8715000 USD 2019-01-01 – 2019-12-31: -8654000 USD · Inspect Operating Cash Flow · Source 2019-01-01 – 2019-12-31: 61000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2019-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -8715000 USD Concept: free-cash-flow Period: 2019-01-01 to 2019-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8654000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170221000010/yten-20201231.htm#954183 Filing: 000112170221000010 Input fundies:CapitalExpenditure: 61000 USD (2019-01-01 to 2019-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170221000010/yten-20201231.htm#957777 Filing: 000112170221000010 The citation records this snapshot. The page link may show a newer release later.
2020 2020-01-01 – 2020-12-31	−USD 10.21 million Exact value Exact value: -10206000 USD 2020-01-01 – 2020-12-31: -10206000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2020-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -10206000 USD Concept: fundies:NetIncome Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:NetIncome: -10206000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170222000008/yten-20211231.htm#1083866 Filing: 000112170222000008 The citation records this snapshot. The page link may show a newer release later.	−USD 8.66 million Exact value Exact value: -8659000 USD 2020-01-01 – 2020-12-31: -8659000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2020-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -8659000 USD Concept: fundies:OperatingCashFlow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -8659000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170222000008/yten-20211231.htm#948957 Filing: 000112170222000008 The citation records this snapshot. The page link may show a newer release later.	USD 76,000 Exact value Exact value: 76000 USD 2020-01-01 – 2020-12-31: 76000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2020-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 76000 USD Concept: fundies:CapitalExpenditure Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2020-12-31&surface=latest&period_type=duration&start=2020-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 76000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170222000008/yten-20211231.htm#952564 Filing: 000112170222000008 The citation records this snapshot. The page link may show a newer release later.	−USD 8.74 million Calculation and evidence -8659000 − 76000 USD Exact free cash flow: -8735000 USD 2020-01-01 – 2020-12-31: -8659000 USD · Inspect Operating Cash Flow · Source 2020-01-01 – 2020-12-31: 76000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2020-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -8735000 USD Concept: free-cash-flow Period: 2020-01-01 to 2020-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -8659000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170222000008/yten-20211231.htm#948957 Filing: 000112170222000008 Input fundies:CapitalExpenditure: 76000 USD (2020-01-01 to 2020-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170222000008/yten-20211231.htm#952564 Filing: 000112170222000008 The citation records this snapshot. The page link may show a newer release later.
2021 2021-01-01 – 2021-12-31	−USD 11.03 million Exact value Exact value: -11031000 USD 2021-01-01 – 2021-12-31: -11031000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2021-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -11031000 USD Concept: fundies:NetIncome Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11031000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000012/yten-20221231.htm#1130248 Filing: 000112170223000012 The citation records this snapshot. The page link may show a newer release later.	−USD 9.25 million Exact value Exact value: -9253000 USD 2021-01-01 – 2021-12-31: -9253000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2021-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -9253000 USD Concept: fundies:OperatingCashFlow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9253000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000012/yten-20221231.htm#1039755 Filing: 000112170223000012 The citation records this snapshot. The page link may show a newer release later.	USD 189,000 Exact value Exact value: 189000 USD 2021-01-01 – 2021-12-31: 189000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2021-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 189000 USD Concept: fundies:CapitalExpenditure Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2021-12-31&surface=latest&period_type=duration&start=2021-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 189000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000012/yten-20221231.htm#1043321 Filing: 000112170223000012 The citation records this snapshot. The page link may show a newer release later.	−USD 9.44 million Calculation and evidence -9253000 − 189000 USD Exact free cash flow: -9442000 USD 2021-01-01 – 2021-12-31: -9253000 USD · Inspect Operating Cash Flow · Source 2021-01-01 – 2021-12-31: 189000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2021-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -9442000 USD Concept: free-cash-flow Period: 2021-01-01 to 2021-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9253000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000012/yten-20221231.htm#1039755 Filing: 000112170223000012 Input fundies:CapitalExpenditure: 189000 USD (2021-01-01 to 2021-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170223000012/yten-20221231.htm#1043321 Filing: 000112170223000012 The citation records this snapshot. The page link may show a newer release later.
2022 2022-01-01 – 2022-12-31	−USD 13.57 million Exact value Exact value: -13566000 USD 2022-01-01 – 2022-12-31: -13566000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2022-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -13566000 USD Concept: fundies:NetIncome Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:NetIncome: -13566000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#907029 Filing: 000112170224000021 The citation records this snapshot. The page link may show a newer release later.	−USD 11.4 million Exact value Exact value: -11404000 USD 2022-01-01 – 2022-12-31: -11404000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2022-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -11404000 USD Concept: fundies:OperatingCashFlow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11404000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#843527 Filing: 000112170224000021 The citation records this snapshot. The page link may show a newer release later.	USD 154,000 Exact value Exact value: 154000 USD 2022-01-01 – 2022-12-31: 154000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2022-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 154000 USD Concept: fundies:CapitalExpenditure Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2022-12-31&surface=latest&period_type=duration&start=2022-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 154000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#846218 Filing: 000112170224000021 The citation records this snapshot. The page link may show a newer release later.	−USD 11.56 million Calculation and evidence -11404000 − 154000 USD Exact free cash flow: -11558000 USD 2022-01-01 – 2022-12-31: -11404000 USD · Inspect Operating Cash Flow · Source 2022-01-01 – 2022-12-31: 154000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2022-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -11558000 USD Concept: free-cash-flow Period: 2022-01-01 to 2022-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11404000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#843527 Filing: 000112170224000021 Input fundies:CapitalExpenditure: 154000 USD (2022-01-01 to 2022-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#846218 Filing: 000112170224000021 The citation records this snapshot. The page link may show a newer release later.
2023 2023-01-01 – 2023-12-31	−USD 14.46 million Exact value Exact value: -14455000 USD 2023-01-01 – 2023-12-31: -14455000 USD Inspect Net Income Open source Share or cite Citation for Net Income · YIELD10 BIOSCIENCE, INC. · 2023-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Net Income: -14455000 USD Concept: fundies:NetIncome Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ANetIncome&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:NetIncome: -14455000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#941938 Filing: 000112170224000021 The citation records this snapshot. The page link may show a newer release later.	−USD 10.07 million Exact value Exact value: -10068000 USD 2023-01-01 – 2023-12-31: -10068000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · YIELD10 BIOSCIENCE, INC. · 2023-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Operating Cash Flow: -10068000 USD Concept: fundies:OperatingCashFlow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3AOperatingCashFlow&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -10068000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#842865 Filing: 000112170224000021 The citation records this snapshot. The page link may show a newer release later.	USD 46,000 Exact value Exact value: 46000 USD 2023-01-01 – 2023-12-31: 46000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · YIELD10 BIOSCIENCE, INC. · 2023-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Capital Expenditure: 46000 USD Concept: fundies:CapitalExpenditure Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702/explain?concept=fundies%3ACapitalExpenditure&period=2023-12-31&surface=latest&period_type=duration&start=2023-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 46000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#845656 Filing: 000112170224000021 The citation records this snapshot. The page link may show a newer release later.	−USD 10.11 million Calculation and evidence -10068000 − 46000 USD Exact free cash flow: -10114000 USD 2023-01-01 – 2023-12-31: -10068000 USD · Inspect Operating Cash Flow · Source 2023-01-01 – 2023-12-31: 46000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · YIELD10 BIOSCIENCE, INC. · 2023-12-31 YIELD10 BIOSCIENCE, INC. (edgar:1121702) Free cash flow: -10114000 USD Concept: free-cash-flow Period: 2023-01-01 to 2023-12-31 Values: Latest reported Published: 2026-11-02T04:04:39Z Snapshot: ee627f6556fb5211802759eaf6cf303e20723b81aae1bd9ee86f802d17b28577 Dimensions: Consolidated View: https://fundies.io/companies/edgar/1121702?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -10068000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#842865 Filing: 000112170224000021 Input fundies:CapitalExpenditure: 46000 USD (2023-01-01 to 2023-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1121702/000112170224000021/yten-20231231.htm#845656 Filing: 000112170224000021 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

94 filings · 3,658 latest values · 3,658 originally reported values

Dataset published 2026-11-02. Source filing dates and reporting periods are shown separately.

Identifiers: 0001121702, 1121702, YTEN, edgar:1121702

Also known as METABOLIX INC, METABOLIX, INC., YIELD10 BIOSCIENCE, INC., YIELD10 BIOSCIENCE, INC. , YIELD10 BIOSCIENCE, INC.

YIELD10 BIOSCIENCE, INC.

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Reported share-count change

Trailing twelve months

Net income

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2023 2023-01-01 – 2023-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation